Location
United Kingdom, Europe
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
SaaS
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
Hardware
Medical Devices
About Investor
Charles Dunn is Principal on the biotech team at SV Health Investors. He helps form and fund companies developing transformational new medicines, with a focus ranging from new company creation to later-stage public and private opportunities. His listed investment range is $100K - $5.0M, with a $1.5M sweet spot. Before SV, he qualified as an ACA at Deloitte, working with life sciences clients including SV portfolio companies, and has an academic background in human genetics and molecular biology from UCL.
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.